Redcare Pharmacy revenue and financials

RDC · Xetra · EUR

Compare Redcare Pharmacy
€63.40Change from previous close: −1.93%Absolute change: −€1.25

Close · November 20, 2026

In the fiscal year ended December 2025, Redcare Pharmacy reported revenue of €2.94B (+24.06% year over year). The net loss was €37.7M.

Annual revenue · 2025: €2.94B
  1. €177.39M2016
  2. €283.99M2017
  3. €539.71M2018
  4. €701.01M2019
  5. €968.06M2020
  6. €1.06B2021
  7. €1.2B2022
  8. €1.8B2023
  9. €2.37B2024
  10. €2.94B2025

Fiscal year ending in December. Sources and method on the page How we analyse stocks.

At a glance

Revenue growth
+24.06%
2025 vs 2024
Net margin
-1.3%
2024: -1.9%

How Redcare Pharmacy is changing

Calculated from the annual statements; each fiscal year is labelled with the year it ends.

Financial data

Amounts in millions of EUR; per-share values in EUR; shares in millions.

Income statement · Annual
Item2025202420232022202120202019201820172016
Total revenue2,9412,3711,7991,2041,060968701540284177
Cost of revenue2,2781,8251,358873794749563440226141
Gross profit66354644033226722013899.357.636.3
Selling, general and administrative68458544437929921416612779.850.1
Operating income-20.1-39.0-3.8-47.2-32.35.6-28.4-27.7-19.2-11.6
EBIT-20.1-39.0-3.8-47.2-32.35.6-28.4-27.7-19.2-11.6
EBITDA2.0-17.014.5-34.0-21.612.8-20.6-20.2-15.6-10.8
Interest expense19.97.88.08.58.610.87.53.42.22.4
Pre-tax income-47.7-47.9-14.3-84.1-77.9-15.9-42.2-34.6-21.4-21.0
Income tax-8.3-1.5-2.7-6.5-3.70.8-5.9-1.0-0.0-2.5
Net income-37.7-45.5-12.0-77.6-74.2-16.8-36.3-33.6-21.4-18.4
Net income to common shareholders-37.7-45.5-12.0-77.6-74.2-16.8-36.3-33.6-21.4-18.4
Basic EPS-1.87-2.27-0.63-4.32-4.15-1.17-2.78-2.79-2.25-3.08
Diluted EPS-1.87-2.27-0.63-4.32-4.15-1.17-2.78-2.79-2.25-3.08
Average shares (basic)20.120.119.218.017.914.413.112.09.56.0
Average shares (diluted)20.120.119.218.017.914.413.112.09.56.0

Companies in the group: same and related industries, similar size